DE69108930T2 - Aus dalbaheptide hergestellte tetrapeptidantibiotika. - Google Patents

Aus dalbaheptide hergestellte tetrapeptidantibiotika.

Info

Publication number
DE69108930T2
DE69108930T2 DE69108930T DE69108930T DE69108930T2 DE 69108930 T2 DE69108930 T2 DE 69108930T2 DE 69108930 T DE69108930 T DE 69108930T DE 69108930 T DE69108930 T DE 69108930T DE 69108930 T2 DE69108930 T2 DE 69108930T2
Authority
DE
Germany
Prior art keywords
group
dalbaheptide
carboxyacid
aglucodalbaheptides
tetrapeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69108930T
Other languages
English (en)
Other versions
DE69108930D1 (de
Inventor
Adriano Malabarba
Romeo Ciabatti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicuron Pharmaceuticals LLC
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Application granted granted Critical
Publication of DE69108930D1 publication Critical patent/DE69108930D1/de
Publication of DE69108930T2 publication Critical patent/DE69108930T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69108930T 1990-12-10 1991-11-28 Aus dalbaheptide hergestellte tetrapeptidantibiotika. Expired - Fee Related DE69108930T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90123672 1990-12-10
PCT/EP1991/002250 WO1992010517A1 (en) 1990-12-10 1991-11-28 Tetrapeptides deriving from dalbaheptide antibiotics

Publications (2)

Publication Number Publication Date
DE69108930D1 DE69108930D1 (de) 1995-05-18
DE69108930T2 true DE69108930T2 (de) 1995-08-24

Family

ID=8204819

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69108930T Expired - Fee Related DE69108930T2 (de) 1990-12-10 1991-11-28 Aus dalbaheptide hergestellte tetrapeptidantibiotika.

Country Status (10)

Country Link
EP (1) EP0561827B1 (de)
JP (1) JP3276632B2 (de)
KR (1) KR100202250B1 (de)
AT (1) ATE121101T1 (de)
CA (1) CA2098098C (de)
DE (1) DE69108930T2 (de)
DK (1) DK0561827T3 (de)
ES (1) ES2071346T3 (de)
IE (1) IE914265A1 (de)
WO (1) WO1992010517A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0698041T3 (da) * 1993-05-19 1997-12-08 Biosearch Italia Spa Syntetiske aglucodalbaheptid-antibiotika.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0409045B1 (de) * 1989-07-18 1997-11-19 Biosearch Italia S.p.A. Aus Dalbaheptide hergestellte Pentapeptid-Antibiotika

Also Published As

Publication number Publication date
CA2098098C (en) 2003-04-08
EP0561827A1 (de) 1993-09-29
EP0561827B1 (de) 1995-04-12
KR100202250B1 (ko) 1999-06-15
ES2071346T3 (es) 1995-06-16
DK0561827T3 (da) 1995-07-03
JPH06503307A (ja) 1994-04-14
JP3276632B2 (ja) 2002-04-22
IE914265A1 (en) 1992-06-17
CA2098098A1 (en) 1992-06-10
KR930703358A (ko) 1993-11-29
ATE121101T1 (de) 1995-04-15
DE69108930D1 (de) 1995-05-18
WO1992010517A1 (en) 1992-06-25

Similar Documents

Publication Publication Date Title
DE68906705T2 (de) Verfahren zur herstellung von baccatin-iii-derivaten und von desacetyl-10-baccatin-iii.
LV12358A (lv) 7-(Aizvietoti)-9-(aizvietoti glicil)-amido-6-demetil-6-deoksitetraciklini
DK0876388T3 (da) Tricykliske erythromycinderivater
ES507716A0 (es) Procedimiento para preparar derivados de 2-oxoazetidina .
FI893842A0 (fi) Menetelmä uuden antibiootin, mersasidiinin, valmistamiseksi
DE69108930T2 (de) Aus dalbaheptide hergestellte tetrapeptidantibiotika.
YU60392A (sh) Novi glikopeptidi i postupak za njihovu proizvodnju
DE69500327D1 (de) Verfahren zur Herstellung von azithromycin Dihydrochloriden
DE69406441T2 (de) Syntetische aglukodalbaheptid-antibiotika
ATE132876T1 (de) Hexapeptidderivate von teicoplanin und verfahren zu deren herstellung
ECSP972170A (es) Compuestos para el tratamiento de infecciones bacterianas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOSEARCH ITALIA S.P.A., GERENZANO, IT

8327 Change in the person/name/address of the patent owner

Owner name: VICURON PHARMACEUTTICALS INC.(N.D.GES.STAATES DELA

8339 Ceased/non-payment of the annual fee